INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol SAAKSHI
MSEI Symbol NOTLISTED
ISIN INE0PSK01027
Name of Company SAAKSHI MEDTECH AND PANELS LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 28-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment MANUFACTURING
Start date and time of board meeting 28-May-2025   15:45:00
End date and time of board meeting 28-May-2025   17:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public Yes
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-05-28
Indicate Company website link for updated RPT policy of the Company https://smtpl.co/policies.html
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
not applicable


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 479743000 924310000
Other income 2963000 5722000
Total Income 482706000 930032000
2 Expenses
(a) Cost of materials consumed 331154000 588084000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -14077000 -10469000
(d) Employee benefit expense 79779000 158269000
(e) Finance costs 1885000 4052000
(f) Depreciation and amortisation expense 21143000 38900000
(g) Other Expenses
1 Other expenses 44749000 85313000
Total other expenses 44749000 85313000
Total expenses 464633000 864149000
3 Profit before exceptional and extraordinary items and tax 18073000 65883000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 18073000 65883000
6 Extraordinary items 0 0
7 Profit before tax 18073000 65883000
8 Tax Expense
Current tax 6156000 18944000
Deferred tax -675000 -990000
Total tax expenses 5481000 17954000
9 Net Profit Loss for the period from continuing operations 12592000 47929000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 12592000 47929000
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 12592000 47929000
17 Details of equity share capital
Paid-up equity share capital 1765600000000 1765600000000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 0
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.71 2.67
Diluted earnings (loss) per share from continuing and discontinued operations 0.71 2.67
20 Debt equity ratio 0.0 0.0
21 Debt service coverage ratio 0.0 0.0
22 Interest service coverage ratio 0.0 0.0
23 Disclosure of notes on financial results Textual Information(1)


Text Block
Textual Information(1) 1. CURRENT TAX INCLUDE PRIOR PERIOD TAX OF 8.32 LAKHS 2. Ratios: Debt Equity Ratio: 0.18 Debe Service Coverage Ratio: 0.97 Interest Service Coverage Ratio: 22.22


Remarks
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 65883000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 4052000
Adjustments for depreciation and amortisation expense 38899000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains -809000
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 42142000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories 12470000
Adjustments for decrease (increase) in trade receivables -45753000
Adjustments for decrease (increase) in other current assets -2078000
Adjustments for increase (decrease) in trade payables -12517000
Adjustments for increase (decrease) in other current liabilities -6435000
Adjustments for provisions 2409000
Total adjustments for working capital -51904000
Total adjustments for reconcile profit (loss) -9762000
Net cash flows from (used in) operations 56121000
Dividends received 0
Interest paid 0
Interest received -4587000
Income taxes paid (refund) 21312000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items 30222000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 30222000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 150045000
Cash advances and loans made to other parties 1954000
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 4586000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items -147413000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -147413000
Cash flows from used in financing activities
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -1912000
Repayments of borrowings 0
Dividends paid 0
Interest paid 4052000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities before extraordinary items -5964000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities -5964000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -123155000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 809000
Net increase (decrease) in cash and cash equivalents -122346000
Cash and cash equivalents cash flow statement at beginning of period 154990000
Cash and cash equivalents cash flow statement at end of period 32644000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 176560000
Reserves and surplus 803887000
Money received against share warrants
Total shareholders' funds 980447000
2 Share application money pending allotment 0
3 Deferred government grants
4 Minority interest
5 Non-current liabilities
Long-term borrowings 140473000
Deferred tax liabilities (net) 0
Foreign currency monetary item translation difference liability account
Other long-term liabilities 42000
Long-term provisions 6162000
Total non-current liabilities 146677000
6 Current liabilities
Short-term borrowings 37762000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 7516000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 72122000
Total Trade payable 79638000
Other current liabilities 25560000
Short-term provisions 43253000
Total current liabilities 186213000
Total equity and liabilities 1313337000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 593890000
Producing properties 0
Intangible assets 6953000
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 132013000
Intangible assets under development or work-in-progress 0
Total Property, Plant and Equipment and Intangible assets 732856000
ii Non-current investments 0
v Deferred tax assets (net) 2293000
vi Foreign currency monetary item translation difference asset account 0
vii Long-term loans and advances 0
viii Other non-current assets 33829000
Total non-current assets 768978000
Current assets
Current investments 0
Inventories 204067000
Trade receivables 218848000
Cash and cash equivalents 32646000
Bank balance other than cash and cash equivalents 0
Short-term loans and advances 78322000
Other current assets 10476000
Total current assets 544359000
Total assets 1313337000
Disclosure of notes on assets and liabilities Textual Information(1)


Text Block
Textual Information(1) Couple of figures have been rounded off wherever necessary


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Signatory Details
Name of signatory
Designation of person
Place
Date


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 SAAKSHI MEDTECH AND PANELS LIMITED VLL SUBCON PRIVATE LIMITED ENTERPRISES WHERE KNP ARE INTERESTED Any other transaction RENT RECEIVED 83000 APROVED BY AUDIT COMMITTEE 83000 2024-05-28 83000 0 0
2 SAAKSHI MEDTECH AND PANELS LIMITED ANIKET VIJAY LATKAR DIRECTOR Remuneration 12106000 APPROVED BY AUDIT COMMITTEE 12106000 2024-05-28 12106000 0 0
3 SAAKSHI MEDTECH AND PANELS LIMITED MAYURI ANIKET LATKAR DIRECTOR Remuneration 8693000 APPROVED BY AUDIT COMMITTEE 8693000 2024-05-28 8693000 0 0
4 SAAKSHI MEDTECH AND PANELS LIMITED CHITRA VIJAY LATKAR DIRECTOR Remuneration 8780000 APPROVED BY AUDIT COMMITTEE 8780000 2024-05-28 8780000 0 0
5 SAAKSHI MEDTECH AND PANELS LIMITED ANIKET VIJAY LATKAR DIRECTOR Loan 500000 APPROVED BY AUDIT COMMITTEE 500000 2024-05-28 500000 533000 33000
Total value of transaction during the reporting period 30162000